We are live on ! Find out more
PRTC

PureTech Health
PRTC

Delisted

PRTC was delisted on the 20th of May, 2026.

Back to rankings

2 hedge funds and large institutions have $759K invested in PureTech Health in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.01% → 0.01% (-0%)

43% less capital invested

Capital invested by funds: $1.33M → $759K (-$574K)

50% less funds holding

Funds holding: 4 → 2 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
PCM
Portolan Capital Management
Massachusetts
-$213K
2
MIFH
Migdal Insurance & Financial Holdings
Israel
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
1
AWM Investment Company
New York
$758K – – –
UBS Group
2
UBS Group
Switzerland
$1K – – –
PCM
3
Portolan Capital Management
Massachusetts
– -$213K -5,749 Closed
MIFH
4
Migdal Insurance & Financial Holdings
Israel
– -$9K -233 Closed

PRTC Hedge Fund Activity: Q1 2022 in Review

2 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q1 2022, worth a combined $759K — down 43% from $1.33M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of PRTC and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Portolan Capital Management, exiting entirely with an estimated $213K sold.

  • 2 institutional investors held PureTech Health (PRTC) as of Q1 2022, down from 4 in Q4 2021.
  • Funds reported $759K of PureTech Health stock for Q1 2022, down 43% quarter-over-quarter.
  • 0 funds opened new PureTech Health positions in Q1 2022 and 2 closed out, a net change of -2 holders.
  • The largest PureTech Health seller in Q1 2022 was Portolan Capital Management, an estimated $213K sold.

Based on aggregated 13F filings for Q1 2022.